P78 Endothelial Dysfunction and Arterial Stiffness During Type 2 Diabetes

Objective: We aimed to study Endothelial dysfunction and Arterial Stiffness in Diabetes mellitus. Methods: 29 women with type 2 diabetes and 8 non-diabetic controls were included. Vascular function was studied with pOpmetre® (Axelife SAS-France) to assess the foot to toe Pulse Wave Velocity; and En...

Full description

Bibliographic Details
Main Authors: Maimouna Toure, Magid Hallab, Souleymane Thiam, Sheikh AB Mane, Farid Belem, Abdoulaye Samb
Format: Article
Language:English
Published: Atlantis Press 2020-02-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125934539/view
id doaj-01a0a07ea8ce4006899e3b46e4194fbf
record_format Article
spelling doaj-01a0a07ea8ce4006899e3b46e4194fbf2020-11-25T02:13:07ZengAtlantis PressArtery Research 1876-44012020-02-0125110.2991/artres.k.191224.108P78 Endothelial Dysfunction and Arterial Stiffness During Type 2 DiabetesMaimouna ToureMagid HallabSouleymane ThiamSheikh AB ManeFarid BelemAbdoulaye SambObjective: We aimed to study Endothelial dysfunction and Arterial Stiffness in Diabetes mellitus. Methods: 29 women with type 2 diabetes and 8 non-diabetic controls were included. Vascular function was studied with pOpmetre® (Axelife SAS-France) to assess the foot to toe Pulse Wave Velocity; and EndoPAT2000® (ITAMAR-Israel) to measure endothelial vasodilatation dependent by measurement of reactive hyperhemic index (RHI). Results: Diabetics were 56 ± 6 years vs 47 ± 9 years. Mean diabetes duration was 9.07 ± 6.15 years. RHI was normal in all controls (1.94 ± 0.68) and abnormal in 51.72% of diabetics (1.83 ± 0.12). An abnormal ftPWV was found in 38% of diabetic subjects (11.6 ± 7.7 m/s) vs 12% of controls (7.7 ± 2.3 m/s, normal <10 m/s). There was a positive correlation between ftPWV and age (r = 0.25; p = 0.001); ftPWV and duration of diabetes (r = 0.12; p = 0.03). At the same time we found a negative correlation between RHI and fasting blood glucose (r = −0.46; p = 0.01), HbA1c (r = −0.37; p = 0.04), triglycerides (r = −0.49; p = 0.03) and total cholesterol (r = −0.37; p = 0.04). In a rapid and non-invasive way, we found endothelial dysfunction in 51.72% of diabetics and arterial stiffness in 38% of them. Conclusion: During diabetes, endothelial dysfunction and arterial stiffness are therefore dependent on the glycemic balance, the duration of diabetes and lipid parameters. However, these two parameters appear independently and differently associated with diabetic disease.https://www.atlantis-press.com/article/125934539/view
collection DOAJ
language English
format Article
sources DOAJ
author Maimouna Toure
Magid Hallab
Souleymane Thiam
Sheikh AB Mane
Farid Belem
Abdoulaye Samb
spellingShingle Maimouna Toure
Magid Hallab
Souleymane Thiam
Sheikh AB Mane
Farid Belem
Abdoulaye Samb
P78 Endothelial Dysfunction and Arterial Stiffness During Type 2 Diabetes
Artery Research
author_facet Maimouna Toure
Magid Hallab
Souleymane Thiam
Sheikh AB Mane
Farid Belem
Abdoulaye Samb
author_sort Maimouna Toure
title P78 Endothelial Dysfunction and Arterial Stiffness During Type 2 Diabetes
title_short P78 Endothelial Dysfunction and Arterial Stiffness During Type 2 Diabetes
title_full P78 Endothelial Dysfunction and Arterial Stiffness During Type 2 Diabetes
title_fullStr P78 Endothelial Dysfunction and Arterial Stiffness During Type 2 Diabetes
title_full_unstemmed P78 Endothelial Dysfunction and Arterial Stiffness During Type 2 Diabetes
title_sort p78 endothelial dysfunction and arterial stiffness during type 2 diabetes
publisher Atlantis Press
series Artery Research
issn 1876-4401
publishDate 2020-02-01
description Objective: We aimed to study Endothelial dysfunction and Arterial Stiffness in Diabetes mellitus. Methods: 29 women with type 2 diabetes and 8 non-diabetic controls were included. Vascular function was studied with pOpmetre® (Axelife SAS-France) to assess the foot to toe Pulse Wave Velocity; and EndoPAT2000® (ITAMAR-Israel) to measure endothelial vasodilatation dependent by measurement of reactive hyperhemic index (RHI). Results: Diabetics were 56 ± 6 years vs 47 ± 9 years. Mean diabetes duration was 9.07 ± 6.15 years. RHI was normal in all controls (1.94 ± 0.68) and abnormal in 51.72% of diabetics (1.83 ± 0.12). An abnormal ftPWV was found in 38% of diabetic subjects (11.6 ± 7.7 m/s) vs 12% of controls (7.7 ± 2.3 m/s, normal <10 m/s). There was a positive correlation between ftPWV and age (r = 0.25; p = 0.001); ftPWV and duration of diabetes (r = 0.12; p = 0.03). At the same time we found a negative correlation between RHI and fasting blood glucose (r = −0.46; p = 0.01), HbA1c (r = −0.37; p = 0.04), triglycerides (r = −0.49; p = 0.03) and total cholesterol (r = −0.37; p = 0.04). In a rapid and non-invasive way, we found endothelial dysfunction in 51.72% of diabetics and arterial stiffness in 38% of them. Conclusion: During diabetes, endothelial dysfunction and arterial stiffness are therefore dependent on the glycemic balance, the duration of diabetes and lipid parameters. However, these two parameters appear independently and differently associated with diabetic disease.
url https://www.atlantis-press.com/article/125934539/view
work_keys_str_mv AT maimounatoure p78endothelialdysfunctionandarterialstiffnessduringtype2diabetes
AT magidhallab p78endothelialdysfunctionandarterialstiffnessduringtype2diabetes
AT souleymanethiam p78endothelialdysfunctionandarterialstiffnessduringtype2diabetes
AT sheikhabmane p78endothelialdysfunctionandarterialstiffnessduringtype2diabetes
AT faridbelem p78endothelialdysfunctionandarterialstiffnessduringtype2diabetes
AT abdoulayesamb p78endothelialdysfunctionandarterialstiffnessduringtype2diabetes
_version_ 1724906259420807168